| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |